▶ 調査レポート

抗ウイルス薬の世界市場2017

• 英文タイトル:Global Anti-Viral Drugs Sales Market Report 2017

Global Anti-Viral Drugs Sales Market Report 2017「抗ウイルス薬の世界市場2017」(市場規模、市場予測)調査レポートです。• レポートコード:A040110072
• 出版社/出版日:QYResearch / 2017年1月20日
• レポート形態:英文、PDF、129ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User License¥440,000 (USD4,000)▷ お問い合わせ
  Enterprise License¥880,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、抗ウイルス薬の世界市場について調査・分析し、抗ウイルス薬のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、抗ウイルス薬産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。(※Sales:抗ウイルス薬の販売量、Revenue:抗ウイルス薬の売上高)

・抗ウイルス薬市場概要
・抗ウイルス薬のメーカー別販売量・メーカー別シェア
・抗ウイルス薬の世界市場:種類別販売量・市場シェア
・抗ウイルス薬の世界市場:用途別販売量・市場シェア
・抗ウイルス薬の世界市場:地域別販売量・市場シェア
・抗ウイルス薬のアメリカ市場規模
・抗ウイルス薬の中国市場規模
・抗ウイルス薬のヨーロッパ市場規模
・抗ウイルス薬の日本市場規模
・抗ウイルス薬の東南アジア市場規模
・抗ウイルス薬のインド市場規模
・抗ウイルス薬のメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・抗ウイルス薬のコスト分析・価格動向
・抗ウイルス薬の産業チェーン(サプライチェーン分析)
・抗ウイルス薬のマーケティング戦略・販売チャネル、流通業者
・抗ウイルス薬市場への影響要因分析
・抗ウイルス薬の世界市場予測
・抗ウイルス薬のアメリカ市場予測
・抗ウイルス薬の中国市場予測
・抗ウイルス薬のヨーロッパ市場予測
・抗ウイルス薬の日本市場予測
・抗ウイルス薬の東南アジア市場予測
・抗ウイルス薬のインド市場予測
・抗ウイルス薬の種類別世界市場予測
・抗ウイルス薬の用途別世界市場予測
...

Notes:Sales, means the sales volume of Anti-Viral Drugs
Revenue, means the sales value of Anti-Viral Drugs

This report studies sales (consumption) of Anti-Viral Drugs in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Roche
Gilead
GlaxoSmithKline
Bristol-Myers-Squibb
Abbott
AstraZeneca
Cipla
Schering-Plough
Johnson & Johnson
Merck & Co

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Anti-Viral Drugs in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Hepatitis-C Antivirals
HIV Antivirals
Herpes Antivirals
Hepatitis-B Antivirals
Influenza Antivirals
Others (Pneumonia, Flu, etc.)
Split by applications, this report focuses on sales, market share and growth rate of Anti-Viral Drugs in each application, can be divided into
Hospitals
Clinics
Ambulatory Surgical Centers

レポート目次

Table of Contents

Global Anti-Viral Drugs Sales Market Report 2017
1 Anti-Viral Drugs Overview
1.1 Product Overview and Scope of Anti-Viral Drugs
1.2 Classification of Anti-Viral Drugs
1.2.1 Hepatitis-C Antivirals
1.2.2 HIV Antivirals
1.2.3 Herpes Antivirals
1.2.4 Hepatitis-B Antivirals
1.2.5 Influenza Antivirals
1.2.6 Others (Pneumonia, Flu, etc.)
1.3 Application of Anti-Viral Drugs
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Anti-Viral Drugs Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Anti-Viral Drugs (2012-2022)
1.5.1 Global Anti-Viral Drugs Sales and Growth Rate (2012-2022)
1.5.2 Global Anti-Viral Drugs Revenue and Growth Rate (2012-2022)

2 Global Anti-Viral Drugs Competition by Manufacturers, Type and Application
2.1 Global Anti-Viral Drugs Market Competition by Manufacturers
2.1.1 Global Anti-Viral Drugs Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Anti-Viral Drugs Revenue and Share by Manufacturers (2012-2017)
2.2 Global Anti-Viral Drugs (Volume and Value) by Type
2.2.1 Global Anti-Viral Drugs Sales and Market Share by Type (2012-2017)
2.2.2 Global Anti-Viral Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Anti-Viral Drugs (Volume and Value) by Regions
2.3.1 Global Anti-Viral Drugs Sales and Market Share by Regions (2012-2017)
2.3.2 Global Anti-Viral Drugs Revenue and Market Share by Regions (2012-2017)
2.4 Global Anti-Viral Drugs (Volume) by Application

3 United States Anti-Viral Drugs (Volume, Value and Sales Price)
3.1 United States Anti-Viral Drugs Sales and Value (2012-2017)
3.1.1 United States Anti-Viral Drugs Sales and Growth Rate (2012-2017)
3.1.2 United States Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
3.1.3 United States Anti-Viral Drugs Sales Price Trend (2012-2017)
3.2 United States Anti-Viral Drugs Sales and Market Share by Manufacturers
3.3 United States Anti-Viral Drugs Sales and Market Share by Type
3.4 United States Anti-Viral Drugs Sales and Market Share by Application

4 China Anti-Viral Drugs (Volume, Value and Sales Price)
4.1 China Anti-Viral Drugs Sales and Value (2012-2017)
4.1.1 China Anti-Viral Drugs Sales and Growth Rate (2012-2017)
4.1.2 China Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
4.1.3 China Anti-Viral Drugs Sales Price Trend (2012-2017)
4.2 China Anti-Viral Drugs Sales and Market Share by Manufacturers
4.3 China Anti-Viral Drugs Sales and Market Share by Type
4.4 China Anti-Viral Drugs Sales and Market Share by Application

5 Europe Anti-Viral Drugs (Volume, Value and Sales Price)
5.1 Europe Anti-Viral Drugs Sales and Value (2012-2017)
5.1.1 Europe Anti-Viral Drugs Sales and Growth Rate (2012-2017)
5.1.2 Europe Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
5.1.3 Europe Anti-Viral Drugs Sales Price Trend (2012-2017)
5.2 Europe Anti-Viral Drugs Sales and Market Share by Manufacturers
5.3 Europe Anti-Viral Drugs Sales and Market Share by Type
5.4 Europe Anti-Viral Drugs Sales and Market Share by Application

6 Japan Anti-Viral Drugs (Volume, Value and Sales Price)
6.1 Japan Anti-Viral Drugs Sales and Value (2012-2017)
6.1.1 Japan Anti-Viral Drugs Sales and Growth Rate (2012-2017)
6.1.2 Japan Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
6.1.3 Japan Anti-Viral Drugs Sales Price Trend (2012-2017)
6.2 Japan Anti-Viral Drugs Sales and Market Share by Manufacturers
6.3 Japan Anti-Viral Drugs Sales and Market Share by Type
6.4 Japan Anti-Viral Drugs Sales and Market Share by Application
7 Southeast Asia Anti-Viral Drugs (Volume, Value and Sales Price)
7.1 Southeast Asia Anti-Viral Drugs Sales and Value (2012-2017)
7.1.1 Southeast Asia Anti-Viral Drugs Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Anti-Viral Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Anti-Viral Drugs Sales and Market Share by Manufacturers
7.3 Southeast Asia Anti-Viral Drugs Sales and Market Share by Type
7.4 Southeast Asia Anti-Viral Drugs Sales and Market Share by Application
8 India Anti-Viral Drugs (Volume, Value and Sales Price)
8.1 India Anti-Viral Drugs Sales and Value (2012-2017)
8.1.1 India Anti-Viral Drugs Sales and Growth Rate (2012-2017)
8.1.2 India Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
8.1.3 India Anti-Viral Drugs Sales Price Trend (2012-2017)
8.2 India Anti-Viral Drugs Sales and Market Share by Manufacturers
8.3 India Anti-Viral Drugs Sales and Market Share by Type
8.4 India Anti-Viral Drugs Sales and Market Share by Application

9 Global Anti-Viral Drugs Manufacturers Analysis
9.1 Roche
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Anti-Viral Drugs Product Type, Application and Specification
9.1.2.1 Hepatitis-C Antivirals
9.1.2.2 HIV Antivirals
9.1.3 Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Gilead
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Anti-Viral Drugs Product Type, Application and Specification
9.2.2.1 Hepatitis-C Antivirals
9.2.2.2 HIV Antivirals
9.2.3 Gilead Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 GlaxoSmithKline
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Anti-Viral Drugs Product Type, Application and Specification
9.3.2.1 Hepatitis-C Antivirals
9.3.2.2 HIV Antivirals
9.3.3 GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Bristol-Myers-Squibb
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Anti-Viral Drugs Product Type, Application and Specification
9.4.2.1 Hepatitis-C Antivirals
9.4.2.2 HIV Antivirals
9.4.3 Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Abbott
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Anti-Viral Drugs Product Type, Application and Specification
9.5.2.1 Hepatitis-C Antivirals
9.5.2.2 HIV Antivirals
9.5.3 Abbott Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 AstraZeneca
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Anti-Viral Drugs Product Type, Application and Specification
9.6.2.1 Hepatitis-C Antivirals
9.6.2.2 HIV Antivirals
9.6.3 AstraZeneca Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Cipla
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Anti-Viral Drugs Product Type, Application and Specification
9.7.2.1 Hepatitis-C Antivirals
9.7.2.2 HIV Antivirals
9.7.3 Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Schering-Plough
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Anti-Viral Drugs Product Type, Application and Specification
9.8.2.1 Hepatitis-C Antivirals
9.8.2.2 HIV Antivirals
9.8.3 Schering-Plough Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Johnson & Johnson
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Anti-Viral Drugs Product Type, Application and Specification
9.9.2.1 Hepatitis-C Antivirals
9.9.2.2 HIV Antivirals
9.9.3 Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Merck & Co
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Anti-Viral Drugs Product Type, Application and Specification
9.10.2.1 Hepatitis-C Antivirals
9.10.2.2 HIV Antivirals
9.10.3 Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview

10 Anti-Viral Drugs Maufacturing Cost Analysis
10.1 Anti-Viral Drugs Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Anti-Viral Drugs
10.3 Manufacturing Process Analysis of Anti-Viral Drugs

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Anti-Viral Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Anti-Viral Drugs Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Anti-Viral Drugs Market Forecast (2017-2022)
14.1 Global Anti-Viral Drugs Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Anti-Viral Drugs Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Anti-Viral Drugs Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Anti-Viral Drugs Price and Trend Forecast (2017-2022)
14.2 Global Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Anti-Viral Drugs Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Anti-Viral Drugs Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Anti-Viral Drugs Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Anti-Viral Drugs
Table Classification of Anti-Viral Drugs
Figure Global Sales Market Share of Anti-Viral Drugs by Type in 2015
Figure Hepatitis-C Antivirals Picture
Figure HIV Antivirals Picture
Figure Herpes Antivirals Picture
Figure Hepatitis-B Antivirals Picture
Figure Influenza Antivirals Picture
Figure Others (Pneumonia, Flu, etc.) Picture
Table Applications of Anti-Viral Drugs
Figure Global Sales Market Share of Anti-Viral Drugs by Application in 2015
Figure Hospitals Examples
Figure Clinics Examples
Figure Ambulatory Surgical Centers Examples
Figure United States Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure China Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure Europe Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure Japan Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure India Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Figure Global Anti-Viral Drugs Sales and Growth Rate (2012-2022)
Figure Global Anti-Viral Drugs Revenue and Growth Rate (2012-2022)
Table Global Anti-Viral Drugs Sales of Key Manufacturers (2012-2017)
Table Global Anti-Viral Drugs Sales Share by Manufacturers (2012-2017)
Figure 2015 Anti-Viral Drugs Sales Share by Manufacturers
Figure 2016 Anti-Viral Drugs Sales Share by Manufacturers
Table Global Anti-Viral Drugs Revenue by Manufacturers (2012-2017)
Table Global Anti-Viral Drugs Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Anti-Viral Drugs Revenue Share by Manufacturers
Table 2016 Global Anti-Viral Drugs Revenue Share by Manufacturers
Table Global Anti-Viral Drugs Sales and Market Share by Type (2012-2017)
Table Global Anti-Viral Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Anti-Viral Drugs by Type (2012-2017)
Figure Global Anti-Viral Drugs Sales Growth Rate by Type (2012-2017)
Table Global Anti-Viral Drugs Revenue and Market Share by Type (2012-2017)
Table Global Anti-Viral Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Anti-Viral Drugs by Type (2012-2017)
Figure Global Anti-Viral Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Anti-Viral Drugs Sales and Market Share by Regions (2012-2017)
Table Global Anti-Viral Drugs Sales Share by Regions (2012-2017)
Figure Sales Market Share of Anti-Viral Drugs by Regions (2012-2017)
Figure Global Anti-Viral Drugs Sales Growth Rate by Regions (2012-2017)
Table Global Anti-Viral Drugs Revenue and Market Share by Regions (2012-2017)
Table Global Anti-Viral Drugs Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Anti-Viral Drugs by Regions (2012-2017)
Figure Global Anti-Viral Drugs Revenue Growth Rate by Regions (2012-2017)
Table Global Anti-Viral Drugs Sales and Market Share by Application (2012-2017)
Table Global Anti-Viral Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Anti-Viral Drugs by Application (2012-2017)
Figure Global Anti-Viral Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure United States Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure United States Anti-Viral Drugs Sales Price Trend (2012-2017)
Table United States Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table United States Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table United States Anti-Viral Drugs Sales by Type (2012-2017)
Table United States Anti-Viral Drugs Market Share by Type (2012-2017)
Table United States Anti-Viral Drugs Sales by Application (2012-2017)
Table United States Anti-Viral Drugs Market Share by Application (2012-2017)
Figure China Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure China Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure China Anti-Viral Drugs Sales Price Trend (2012-2017)
Table China Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table China Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table China Anti-Viral Drugs Sales by Type (2012-2017)
Table China Anti-Viral Drugs Market Share by Type (2012-2017)
Table China Anti-Viral Drugs Sales by Application (2012-2017)
Table China Anti-Viral Drugs Market Share by Application (2012-2017)
Figure Europe Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure Europe Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure Europe Anti-Viral Drugs Sales Price Trend (2012-2017)
Table Europe Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table Europe Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table Europe Anti-Viral Drugs Sales by Type (2012-2017)
Table Europe Anti-Viral Drugs Market Share by Type (2012-2017)
Table Europe Anti-Viral Drugs Sales by Application (2012-2017)
Table Europe Anti-Viral Drugs Market Share by Application (2012-2017)
Figure Japan Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure Japan Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure Japan Anti-Viral Drugs Sales Price Trend (2012-2017)
Table Japan Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table Japan Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table Japan Anti-Viral Drugs Sales by Type (2012-2017)
Table Japan Anti-Viral Drugs Market Share by Type (2012-2017)
Table Japan Anti-Viral Drugs Sales by Application (2012-2017)
Table Japan Anti-Viral Drugs Market Share by Application (2012-2017)
Figure Southeast Asia Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Anti-Viral Drugs Sales Price Trend (2012-2017)
Table Southeast Asia Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table Southeast Asia Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table Southeast Asia Anti-Viral Drugs Sales by Type (2012-2017)
Table Southeast Asia Anti-Viral Drugs Market Share by Type (2012-2017)
Table Southeast Asia Anti-Viral Drugs Sales by Application (2012-2017)
Table Southeast Asia Anti-Viral Drugs Market Share by Application (2012-2017)
Figure India Anti-Viral Drugs Sales and Growth Rate (2012-2017)
Figure India Anti-Viral Drugs Revenue and Growth Rate (2012-2017)
Figure India Anti-Viral Drugs Sales Price Trend (2012-2017)
Table India Anti-Viral Drugs Sales by Manufacturers (2012-2017)
Table India Anti-Viral Drugs Market Share by Manufacturers (2012-2017)
Table India Anti-Viral Drugs Sales by Type (2012-2017)
Table India Anti-Viral Drugs Market Share by Type (2012-2017)
Table India Anti-Viral Drugs Sales by Application (2012-2017)
Table India Anti-Viral Drugs Market Share by Application (2012-2017)
Table Roche Basic Information List
Table Roche Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Anti-Viral Drugs Global Market Share (2012-2017)
Table Gilead Basic Information List
Table Gilead Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Gilead Anti-Viral Drugs Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Anti-Viral Drugs Global Market Share (2012-2017)
Table Bristol-Myers-Squibb Basic Information List
Table Bristol-Myers-Squibb Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bristol-Myers-Squibb Anti-Viral Drugs Global Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Anti-Viral Drugs Global Market Share (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure AstraZeneca Anti-Viral Drugs Global Market Share (2012-2017)
Table Cipla Basic Information List
Table Cipla Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Cipla Anti-Viral Drugs Global Market Share (2012-2017)
Table Schering-Plough Basic Information List
Table Schering-Plough Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Schering-Plough Anti-Viral Drugs Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Anti-Viral Drugs Global Market Share (2012-2017)
Table Merck & Co Basic Information List
Table Merck & Co Anti-Viral Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck & Co Anti-Viral Drugs Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Viral Drugs
Figure Manufacturing Process Analysis of Anti-Viral Drugs
Figure Anti-Viral Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti-Viral Drugs Major Manufacturers in 2015
Table Major Buyers of Anti-Viral Drugs
Table Distributors/Traders List
Figure Global Anti-Viral Drugs Sales and Growth Rate Forecast (2017-2022)
Figure Global Anti-Viral Drugs Revenue and Growth Rate Forecast (2017-2022)
Table Global Anti-Viral Drugs Sales Forecast by Regions (2017-2022)
Table Global Anti-Viral Drugs Sales Forecast by Type (2017-2022)
Table Global Anti-Viral Drugs Sales Forecast by Application (2017-2022)